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Abstract  
The lip represents an anatomical area of the interface between the skin and oral mucosa. It is, therefore, not 
entirely surprising that SCC of the lip exhibits mixed features between cutaneous and oral mucosal SCC, namely 
regarding risk factors and biological behaviour. The main risk factors for lip SCC include ultraviolet radiation 
exposure, low phototype, tobacco and alcohol use, and immunosuppression. Lip SCC usually presents clinically 
as a nodule or a tumour with a keratotic surface that commonly ulcerates. There is often a background of actinic 
cheilitis. The particularly exuberant presentation of our case can most probably be explained by the long evolution 
of a tumour before the patient reached medical attention. Patients with regional lymph node metastasis are 
usually offered regional lymph node dissection (usually of the neck). Radiotherapy and/or chemotherapy may be 
used in advanced cases, particularly in unresectable tumours, tumours with high-risk features and metastatic 
disease. The large size of a tumour in our case, most probably due to its long evolution, highlights the importance 
of timely diagnosis to avoid such extreme presentations and the consequent need for more aggressive treatment. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
 The lip represents an anatomical area of the 
interface between the skin and oral mucosa [1]. It is, 
therefore, not entirely surprising that SCC of the lip 
exhibits mixed features between cutaneous and oral 
mucosal SCC, namely regarding risk factors and 
biological behaviour [1]. The main risk factors for lip 
SCC include ultraviolet radiation exposure, low 
phototype, tobacco and alcohol use, and 
immunosuppression [1]. Poor oral hygiene and dental 
status are also very frequent findings in patients with 
this neoplasm [2]. Recently, it was found that use of 
photosensitive drugs, particularly hydrochlorothiazide, 
may significantly increase the relative risk of lip SCC 
[3]. 
 
 
Case Presentation 
 
A 94-year-old female was presented to the 
dermatology department with a large ulcerated tumour 
of the lower lip that was evolving for seven years. The 
patient lived in a rural area in Bulgaria and had a 
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history of significant chronic sun exposure. Clinical 
examination disclosed a large tumoural mass 
occupying virtually the whole extension of the 
vermillion of the lower lip and extending to the 
surrounding perioral skin (Figs. 1a, 1b, 1c, 1d). The 
lesion was markedly exophytic with an ulcerated 
friable surface covered with black haemorrhagic 
crusts (Figures 1a to 1c). Oral cavity examination 
revealed poor oral hygiene and dental status (Figure 
1d). Incisional biopsy was consistent with squamous 
cell carcinoma (SCC). The patient is currently 
scheduled for surgical treatment. 
 
Figure 1: (1a-1d) A tumoural mass occupying virtually the whole 
extension of the vermillion of the lower lip and extending to the 
surrounding perioral skin. The surface of a tumour is covered with 
black haemorrhagic crusts (Figures 1a to 1c). Poor oral hygiene 
and dental status (Figure 1d) 
 
 
Discussion 
 
First-line treatment of lip SCC is surgical 
excision, whenever possible [4]. Patients with regional 
lymph node metastasis are usually offered regional 
lymph node dissection (usually of the neck) [4]. 
Radiotherapy and/or chemotherapy may be used in 
advanced cases, particularly in unresectable tumours, 
tumours with high-risk features and metastatic 
disease [4]. 
Regarding prognosis, lip SCC displays 
intermediate behaviour between cutaneous SCC and 
SCC of the oral mucosa, with an overall 5 - year 
survival rate of 82,1% [5]. The risk of nodal metastasis 
varies widely with primary tumour staging (e.g. T1 
tumours have the nodal disease in 3, 4 to 7% of 
cases, whereas in T4 tumours this percentage may 
vary from 17 to 100%, depending on the studies). Lip 
SCC is thus considered a high-risk category within the 
group of cutaneous SCC [1][2][5]. Additional 
prognostic factors include the degree of differentiation 
of a tumour, depth of invasion and perineural invasion 
[1][2][3][4][5][6]. In a recent study, elderly (over 80 
years-old) and non-white patients were found to have 
a poorer prognosis [6]. 
The large size of a tumour in our case, most 
probably due to its long evolution, highlights the 
importance of timely diagnosis to avoid such extreme 
presentations and the consequent need for more 
aggressive treatment (Figs.1a-1d). 
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